Kimberly-Clark completes Kenvue deal, forming a global health platform

Kimberly-Clark said it has completed its acquisition of Kenvue, bringing the consumer-health company’s portfolio into Kimberly-Clark. The announcement describes the combined business as spanning highly complementary categories and geographies and includes 10 iconic billion-dollar brands.

The deal follows Kimberly-Clark’s plan to expand beyond its existing personal-care portfolio through Kenvue’s consumer-health brands. Kimberly-Clark reported $16.4 billion of fiscal 2025 revenue, while Kenvue reported $15.1 billion for its fiscal year, giving the transaction scale across adjacent branded-consumer categories, though the two figures come from different fiscal periods.

For Kimberly-Clark, the mechanism is now operational: its growth engine and operating model are intended to be applied across the combined portfolio. Kenvue contributes consumer-health exposure, while Kimberly-Clark brings its existing care products, distribution and corporate infrastructure into the enlarged platform.

The announcement’s strategic framing does not by itself establish the pace of integration, cost savings, revenue growth or the effect on earnings. Kimberly-Clark’s latest annual data showed a 2.1% year-over-year revenue decline and a 12.3% net margin; Kenvue’s showed the same revenue decline and a 9.7% net margin, but those results are historical and are not combined post-acquisition results.

The next evidence will be Kimberly-Clark’s first quarterly reporting period that includes the acquired business, including integration costs, brand performance and any updated outlook. Investors will also need disclosures on the timing of synergies and the contribution from Kenvue’s portfolio to determine how much of the strategic rationale is translating into operating results.